Validation request received

12:54:18 PM
step
Discovery phase started

12:54:18 PM
DiscoveryAgent
Discovery agent started for hypothesis: Molecular : Metformin activates AMPK signaling pathways in cancer cells.

12:54:21 PM
QueryConstructorAgent
Building advanced queries

12:54:26 PM
QueryConstructorAgent
Advanced query ready: {"query":"((\"Metformin\"[MeSH Terms] OR \"Metformin\"[All Fields]) AND (\"AMPK signaling pathway\"[MeSH Terms] OR \"AMPK signaling\"[All Fields] OR \"AMP-activated protein kinase\"[All Fields]) AND (\"cancer cells\"[MeSH Terms] OR \"cancer\"[All Fields]))"}

12:54:26 PM
DiscoveryAgent
Running discovery across data sources

12:54:26 PM
DiscoveryAgent
Querying PubMedClient for related papers.

12:54:30 PM
DiscoveryAgent
Fetching 5 articles from PubMedClient

12:54:34 PM
step
Discovered 5 articles for sub-hypothesis: subHypothesisTitle='Metformin activates AMPK signaling pathways in cancer cells.' rationale='AMPK activation is a known mechanism of Metformin, which can inhibit cancer cell growth and proliferation, linking it to potential reductions in cancer mortality.'

12:54:34 PM
DiscoveryAgent
Discovery agent started for hypothesis: Molecular : Metformin inhibits mTOR signaling in cancer cells.

12:54:38 PM
QueryConstructorAgent
Building advanced queries

12:54:42 PM
QueryConstructorAgent
Advanced query ready: {"query":"((\"Metformin\"[MeSH Terms] OR \"Metformin\"[All Fields]) AND (\"mTOR signaling\"[MeSH Terms] OR \"mTOR signaling\"[All Fields]) AND (\"cancer cells\"[MeSH Terms] OR \"cancer cells\"[All Fields]))"}

12:54:42 PM
DiscoveryAgent
Running discovery across data sources

12:54:42 PM
DiscoveryAgent
Querying PubMedClient for related papers.

12:54:46 PM
DiscoveryAgent
Fetching 5 articles from PubMedClient

12:54:52 PM
step
Discovered 5 articles for sub-hypothesis: subHypothesisTitle='Metformin inhibits mTOR signaling in cancer cells.' rationale='mTOR inhibition is associated with reduced cancer cell survival and proliferation, and Metformin is known to suppress mTOR activity through AMPK activation.'

12:54:52 PM
DiscoveryAgent
Discovery agent started for hypothesis: Molecular : Metformin reduces glucose availability in the tumor microenvironment.

12:54:54 PM
QueryConstructorAgent
Building advanced queries

12:54:57 PM
QueryConstructorAgent
Advanced query ready: {"query":"((\"Metformin\"[MeSH Terms] OR \"Metformin\"[All Fields]) AND (\"glucose\"[MeSH Terms] OR \"glucose\"[All Fields]) AND (\"tumor microenvironment\"[MeSH Terms] OR \"tumor microenvironment\"[All Fields]))"}

12:54:57 PM
DiscoveryAgent
Running discovery across data sources

12:54:57 PM
DiscoveryAgent
Querying PubMedClient for related papers.

12:55:01 PM
step
No articles found for sub-hypothesis: Metformin reduces glucose availability in the tumor microenvironment.

12:55:01 PM
DiscoveryAgent
Discovery agent started for hypothesis: Clinical : Diabetic patients on Metformin have lower cancer-specific mortality rates compared to those not on Metformin.

12:55:04 PM
QueryConstructorAgent
Building advanced queries

12:55:09 PM
QueryConstructorAgent
Advanced query ready: {"query":"((\"diabetes mellitus\"[MeSH Terms] OR \"diabetic patients\") AND \"metformin\"[MeSH Terms] AND \"cancer-specific mortality\"[All Fields]) AND (\"Clinical Trial\"[Publication Type] OR \"Randomized Controlled Trial\"[Publication Type])"}

12:55:09 PM
DiscoveryAgent
Running discovery across data sources

12:55:09 PM
DiscoveryAgent
Querying PubMedClient for related papers.

12:55:12 PM
step
No articles found for sub-hypothesis: Diabetic patients on Metformin have lower cancer-specific mortality rates compared to those not on Metformin.

12:55:12 PM
step
Scoring phase started

12:55:12 PM
ScoringAgent
Scoring 5 articles for Sub-Hypothesis : Metformin activates AMPK signaling pathways in cancer cells.

12:55:12 PM
ScoringAgent
Scoring article 1/5: Metformin's anticancer odyssey: Revealing multifaceted mechanisms across diverse neoplastic terrains- a critical review. <> PaperId: 40058683

12:55:24 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 40058683

12:55:24 PM
ScoringAgentFunction
Quality: Sample Size - This study includes 2 participants. | score: 0.06 <> PaperId: 40058683

12:55:24 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 40058683

12:55:26 PM
ScoringAgentFunction
Citation data unavailable | score 0.0 <> PaperId: 40058683

12:55:31 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.06, recency=1.00, citation=0.00): 0.37 <> PaperId: 40058683

12:55:34 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.94 - High <> PaperId: 40058683

12:55:35 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.8 - Very plausible, findings align perfectly with established biology. <> PaperId: 40058683

12:55:36 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.6 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 40058683

12:55:36 PM
ScoringAgentFunction
Composite score (quality=0.37, relevance=0.94, plausibility=0.80, novelty=0.60): 0.63 <> PaperId: 40058683

12:55:36 PM
ScoringAgentFunction
Final score: 0.63 <> PaperId: 40058683

12:55:40 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 40058683

12:55:45 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 40058683

12:55:46 PM
ScoringAgentFunction
Scoring finished <> PaperId: 40058683

12:55:12 PM
ScoringAgent
Scoring article 2/5: Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines. <> PaperId: 39026155

12:55:32 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 39026155

12:55:34 PM
ScoringAgentFunction
Sample size data unavailable | score 0.0 <> PaperId: 39026155

12:55:35 PM
ScoringAgentFunction
Quality: Recency - this study was published 1 year(s) ago on 2024. | score: 0.9 <> PaperId: 39026155

12:55:36 PM
ScoringAgentFunction
Quality: Citation - This study has been cited 3 times. | score: 0.1 <> PaperId: 39026155

12:55:36 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.00, recency=0.90, citation=0.10): 0.36 <> PaperId: 39026155

12:55:36 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.93 - High <> PaperId: 39026155

12:55:40 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.6 - Plausible, findings fit known mechanisms with minor gaps. <> PaperId: 39026155

12:55:46 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.7 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 39026155

12:55:46 PM
ScoringAgentFunction
Composite score (quality=0.36, relevance=0.93, plausibility=0.60, novelty=0.70): 0.6 <> PaperId: 39026155

12:55:46 PM
ScoringAgentFunction
Final score: 0.6 <> PaperId: 39026155

12:55:48 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 39026155

12:55:50 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 39026155

12:55:50 PM
ScoringAgentFunction
Scoring finished <> PaperId: 39026155

12:55:59 PM
ScoringAgent
Scoring article 1/5: Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines. <> PaperId: 39026155

12:56:18 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 39026155

12:56:20 PM
ScoringAgentFunction
Sample size data unavailable | score 0.0 <> PaperId: 39026155

12:56:20 PM
ScoringAgentFunction
Quality: Recency - this study was published 1 year(s) ago on 2024. | score: 0.9 <> PaperId: 39026155

12:56:20 PM
ScoringAgentFunction
Quality: Citation - This study has been cited 3 times. | score: 0.1 <> PaperId: 39026155

12:56:24 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.00, recency=0.90, citation=0.10): 0.36 <> PaperId: 39026155

12:56:31 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.93 - High <> PaperId: 39026155

12:56:31 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.6 - Plausible, findings fit known mechanisms with minor gaps. <> PaperId: 39026155

12:56:32 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.7 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 39026155

12:56:32 PM
ScoringAgentFunction
Composite score (quality=0.36, relevance=0.93, plausibility=0.60, novelty=0.70): 0.6 <> PaperId: 39026155

12:56:32 PM
ScoringAgentFunction
Final score: 0.6 <> PaperId: 39026155

12:56:34 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 39026155

12:56:36 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 39026155

12:56:36 PM
ScoringAgentFunction
Scoring finished <> PaperId: 39026155

12:55:12 PM
ScoringAgent
Scoring article 3/5: Metformin Enhances the Chemosensitivity of Gastric Cancer to Cisplatin by Downregulating Nrf2 Level. <> PaperId: 40264514

12:55:23 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 40264514

12:55:24 PM
ScoringAgentFunction
Quality: Sample Size - This study includes 2 participants. | score: 0.06 <> PaperId: 40264514

12:55:24 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 40264514

12:55:26 PM
ScoringAgentFunction
Citation data unavailable | score 0.0 <> PaperId: 40264514

12:55:31 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.06, recency=1.00, citation=0.00): 0.37 <> PaperId: 40264514

12:55:34 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.93 - High <> PaperId: 40264514

12:55:34 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.4 - Unclear, mechanism is not well defined but not contradictory. <> PaperId: 40264514

12:55:36 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.5 - Routine, confirms known findings in a different context or population. <> PaperId: 40264514

12:55:36 PM
ScoringAgentFunction
Composite score (quality=0.37, relevance=0.93, plausibility=0.40, novelty=0.50): 0.54 <> PaperId: 40264514

12:55:36 PM
ScoringAgentFunction
Final score: 0.54 <> PaperId: 40264514

12:55:38 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 40264514

12:55:43 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 40264514

12:55:46 PM
ScoringAgentFunction
Scoring finished <> PaperId: 40264514

12:55:12 PM
ScoringAgent
Scoring article 4/5: Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling. <> PaperId: 39971923

12:55:20 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 39971923

12:55:20 PM
ScoringAgentFunction
Quality: Sample Size - This study includes 2 participants. | score: 0.06 <> PaperId: 39971923

12:55:21 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 39971923

12:55:21 PM
ScoringAgentFunction
Quality: Citation - This study has been cited 3 times. | score: 0.1 <> PaperId: 39971923

12:55:21 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.06, recency=1.00, citation=0.10): 0.39 <> PaperId: 39971923

12:55:21 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.93 - High <> PaperId: 39971923

12:55:22 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.6 - Plausible, findings fit known mechanisms with minor gaps. <> PaperId: 39971923

12:55:22 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.6 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 39971923

12:55:24 PM
ScoringAgentFunction
Composite score (quality=0.39, relevance=0.93, plausibility=0.60, novelty=0.60): 0.6 <> PaperId: 39971923

12:55:24 PM
ScoringAgentFunction
Final score: 0.6 <> PaperId: 39971923

12:55:26 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 39971923

12:55:29 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 39971923

12:55:32 PM
ScoringAgentFunction
Scoring finished <> PaperId: 39971923

12:55:59 PM
ScoringAgent
Scoring article 4/5: Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling. <> PaperId: 39971923

12:56:10 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 39971923

12:56:11 PM
ScoringAgentFunction
Quality: Sample Size - This study includes 2 participants. | score: 0.06 <> PaperId: 39971923

12:56:11 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 39971923

12:56:13 PM
ScoringAgentFunction
Quality: Citation - This study has been cited 3 times. | score: 0.1 <> PaperId: 39971923

12:56:16 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.06, recency=1.00, citation=0.10): 0.39 <> PaperId: 39971923

12:56:16 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.93 - High <> PaperId: 39971923

12:56:17 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.5 - Unclear, mechanism is not well defined but not contradictory. <> PaperId: 39971923

12:56:19 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.6 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 39971923

12:56:20 PM
ScoringAgentFunction
Composite score (quality=0.39, relevance=0.93, plausibility=0.50, novelty=0.60): 0.58 <> PaperId: 39971923

12:56:20 PM
ScoringAgentFunction
Final score: 0.58 <> PaperId: 39971923

12:56:22 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 39971923

12:56:26 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 39971923

12:56:31 PM
ScoringAgentFunction
Scoring finished <> PaperId: 39971923

12:55:12 PM
ScoringAgent
Scoring article 5/5: Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway. <> PaperId: 40140842

12:55:21 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 40140842

12:55:21 PM
ScoringAgentFunction
Sample size data unavailable | score 0.0 <> PaperId: 40140842

12:55:21 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 40140842

12:55:21 PM
ScoringAgentFunction
Quality: Citation - This study has been cited 1 times. | score: 0.0 <> PaperId: 40140842

12:55:21 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.00, recency=1.00, citation=0.00): 0.36 <> PaperId: 40140842

12:55:22 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.9 - High <> PaperId: 40140842

12:55:23 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.5 - Unclear, mechanism is not well defined but not contradictory. <> PaperId: 40140842

12:55:24 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.6 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 40140842

12:55:24 PM
ScoringAgentFunction
Composite score (quality=0.36, relevance=0.90, plausibility=0.50, novelty=0.60): 0.56 <> PaperId: 40140842

12:55:26 PM
ScoringAgentFunction
Final score: 0.56 <> PaperId: 40140842

12:55:31 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 40140842

12:55:34 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 40140842

12:55:34 PM
ScoringAgentFunction
Scoring finished <> PaperId: 40140842

12:55:59 PM
ScoringAgent
Scoring article 5/5: Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway. <> PaperId: 40140842

12:56:11 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 40140842

12:56:11 PM
ScoringAgentFunction
Sample size data unavailable | score 0.0 <> PaperId: 40140842

12:56:11 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 40140842

12:56:13 PM
ScoringAgentFunction
Quality: Citation - This study has been cited 1 times. | score: 0.0 <> PaperId: 40140842

12:56:16 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.00, recency=1.00, citation=0.00): 0.36 <> PaperId: 40140842

12:56:16 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.9 - High <> PaperId: 40140842

12:56:18 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.5 - Unclear, mechanism is not well defined but not contradictory. <> PaperId: 40140842

12:56:20 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.6 - Novel, introduces a new angle or meaningful extension to known findings. <> PaperId: 40140842

12:56:20 PM
ScoringAgentFunction
Composite score (quality=0.36, relevance=0.90, plausibility=0.50, novelty=0.60): 0.56 <> PaperId: 40140842

12:56:20 PM
ScoringAgentFunction
Final score: 0.56 <> PaperId: 40140842

12:56:24 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 40140842

12:56:31 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 40140842

12:56:31 PM
ScoringAgentFunction
Scoring finished <> PaperId: 40140842

12:55:56 PM
ScoringAgent
Scoring complete for Sub-Hypothesis : Metformin activates AMPK signaling pathways in cancer cells.

12:55:56 PM
step
Scored 5 article for sub-hypothesis: Metformin activates AMPK signaling pathways in cancer cells.

12:55:59 PM
ScoringAgent
Scoring 5 articles for Sub-Hypothesis : Metformin inhibits mTOR signaling in cancer cells.

12:55:59 PM
ScoringAgent
Scoring article 2/5: Identification and validation of hub genes for kidney renal clear cell carcinoma treated with metformin and everolimus combination therapy. <> PaperId: 40792151

12:56:10 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 40792151

12:56:11 PM
ScoringAgentFunction
Sample size data unavailable | score 0.0 <> PaperId: 40792151

12:56:11 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 40792151

12:56:13 PM
ScoringAgentFunction
Citation data unavailable | score 0.0 <> PaperId: 40792151

12:56:16 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.00, recency=1.00, citation=0.00): 0.36 <> PaperId: 40792151

12:56:16 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.92 - High <> PaperId: 40792151

12:56:17 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.5 - Unclear, mechanism is not well defined but not contradictory. <> PaperId: 40792151

12:56:19 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.5 - Routine, confirms known findings in a different context or population. <> PaperId: 40792151

12:56:20 PM
ScoringAgentFunction
Composite score (quality=0.36, relevance=0.92, plausibility=0.50, novelty=0.50): 0.55 <> PaperId: 40792151

12:56:20 PM
ScoringAgentFunction
Final score: 0.55 <> PaperId: 40792151

12:56:23 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 40792151

12:56:28 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 40792151

12:56:31 PM
ScoringAgentFunction
Scoring finished <> PaperId: 40792151

12:55:59 PM
ScoringAgent
Scoring article 3/5: Metformin attenuates O-GlcNAc modification to improve renal function via AMPK/mTOR signaling in diabetic nephropathy. <> PaperId: 41203135

12:56:08 PM
ScoringAgentFunction
Quality: Study design - The study design has been evaluated as other with a rigor score of 0.4. - Limited confidence, lacks clear methodological structure. <> PaperId: 41203135

12:56:08 PM
ScoringAgentFunction
Sample size data unavailable | score 0.0 <> PaperId: 41203135

12:56:08 PM
ScoringAgentFunction
Quality: Recency - this study was published this year. | score: 1.0 <> PaperId: 41203135

12:56:08 PM
ScoringAgentFunction
Citation data unavailable | score 0.0 <> PaperId: 41203135

12:56:08 PM
ScoringAgentFunction
Quality score (design=0.40, sample=0.00, recency=1.00, citation=0.00): 0.36 <> PaperId: 41203135

12:56:08 PM
ScoringAgentFunction
Relevance : This article has a relevance score of: 0.92 - High <> PaperId: 41203135

12:56:09 PM
ScoringAgentFunction
Plausibility: This study has a plausibility score of 0.3 - Questionable, some biological concerns about validity. <> PaperId: 41203135

12:56:09 PM
ScoringAgentFunction
Novelty: This study has a novelty score of 0.3 - Incremental, minor variation on existing findings. <> PaperId: 41203135

12:56:11 PM
ScoringAgentFunction
Composite score (quality=0.36, relevance=0.92, plausibility=0.30, novelty=0.30): 0.48 <> PaperId: 41203135

12:56:11 PM
ScoringAgentFunction
Final score: 0.48 <> PaperId: 41203135

12:56:13 PM
ScoringAgentFunction
Generated grounded explanation <> PaperId: 41203135

12:56:16 PM
ScoringAgentFunction
Generated quality explanation <> PaperId: 41203135

12:56:16 PM
ScoringAgentFunction
Scoring finished <> PaperId: 41203135

12:56:41 PM
ScoringAgent
Scoring complete for Sub-Hypothesis : Metformin inhibits mTOR signaling in cancer cells.

12:56:41 PM
step
Scored 5 article for sub-hypothesis: Metformin inhibits mTOR signaling in cancer cells.

12:56:46 PM
step
Scoring phase finished

12:56:46 PM
step
Validation pipeline complete

12:56:46 PM
complete
Process finished.